search
Back to results

Cardiac Rehab for Advanced Heart Failure-LVAD Candidates

Primary Purpose

Heart Failure

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Strength Training for Frailty
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Heart Failure focused on measuring advanced heart failure, NYHA Class III-IV, frailty, cardiac rehabilitation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Candidate for a Left Ventricular Assist Device (LVAD)
  • Advanced Heart Failure as determined by New York Heart Association classification III or IV

Exclusion Criteria:

  • Unable to perform physical activities required by protocol due to anatomic or musculoskeletal comorbidities
  • Physical activity is contraindicated

Sites / Locations

  • Mayo Clinic-Rochester

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Cardiac Rehabilitation

Arm Description

Strength Training for Frailty: All patients enrolled will be enrolled in 6 weeks of cardiac rehabilitation for the pilot study.

Outcomes

Primary Outcome Measures

Change in frailty marker handgrip strength
Frailty is assessed by the strength of a participant's handgrip, measured using a commercial device.
Change in frailty marker gait speed
Frailty is assessed by the strength of a participant's gait speed, measured using a commercial device.

Secondary Outcome Measures

Change in New York Heart Association (NYHA) classification
New York Heart Association (NYHA) Classification Scale Early-Stage Heart Failure NYHA Class I No symptoms at any level of exertion and no limitation in ordinary physical activity. NYHA Class II Mild symptoms and slight limitation during regular activity. Comfortable at rest. Advanced-Stage Heart Failure NYHA Class III Noticeable limitation due to symptoms, even during minimal activity. Comfortable only at rest. NYHA Class IV Severe limitations. Experience symptoms even while at rest (sitting in a recliner or watching TV).
Change in Minnesota Living with Heart Failure (MLHF) score
A participant's quality of life assessed by Minnesota Living with Heart Failure (MLHF) questionnaire score.
Change in KCCQ score
A participant's quality of life assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) questionnaire score.

Full Information

First Posted
April 25, 2017
Last Updated
June 21, 2018
Sponsor
Mayo Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT03132441
Brief Title
Cardiac Rehab for Advanced Heart Failure-LVAD Candidates
Official Title
A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients Undergoing Evaluation for Left Ventricular Assist Device (LVAD) Placement
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Major changes to study that were better suited to creating a whole new study
Study Start Date
April 2017 (Anticipated)
Primary Completion Date
February 2018 (Anticipated)
Study Completion Date
February 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is a pilot study evaluating the feasibility and early efficacy of cardiac rehabilitation to improve frailty and symptoms in patients with advanced heart failure (NYHA class III-IV), who are being considered for LVAD therapy.
Detailed Description
Frailty in patients with advanced heart failure is not thoroughly described, but in those studies that assessed frailty, it was a common phenomenon. Furthermore, some data suggest an association between pre-LVAD implant frailty and post-implant complications and survival. Interventions for frailty have been utilized in various populations, including the elderly frail and the frail from cardiovascular causes. These interventions target physical strengthening and endurance and have been shown on occasion to improve functional outcomes. The current study, a pilot study, seeks to assess frailty in a prospective cohort of patients being evaluated in Heart Failure Clinic for consideration of LVAD implantation due to NYHA class III-IV dyspnea and enroll these patients in a six-week focused cardiac rehabilitation protocol aimed at improving frailty and functional independence. The primary endpoint of the study is improvement in frailty markers at the end (gait speed, handgrip strength), and secondary endpoints include improvement in the indices of quality of life and symptomatology via validated questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
Keywords
advanced heart failure, NYHA Class III-IV, frailty, cardiac rehabilitation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Single arm pilot study
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cardiac Rehabilitation
Arm Type
Experimental
Arm Description
Strength Training for Frailty: All patients enrolled will be enrolled in 6 weeks of cardiac rehabilitation for the pilot study.
Intervention Type
Other
Intervention Name(s)
Strength Training for Frailty
Intervention Description
Cardiac Rehabilitation, abbreviated course
Primary Outcome Measure Information:
Title
Change in frailty marker handgrip strength
Description
Frailty is assessed by the strength of a participant's handgrip, measured using a commercial device.
Time Frame
Baseline, 6 weeks
Title
Change in frailty marker gait speed
Description
Frailty is assessed by the strength of a participant's gait speed, measured using a commercial device.
Time Frame
Baseline, 6 weeks
Secondary Outcome Measure Information:
Title
Change in New York Heart Association (NYHA) classification
Description
New York Heart Association (NYHA) Classification Scale Early-Stage Heart Failure NYHA Class I No symptoms at any level of exertion and no limitation in ordinary physical activity. NYHA Class II Mild symptoms and slight limitation during regular activity. Comfortable at rest. Advanced-Stage Heart Failure NYHA Class III Noticeable limitation due to symptoms, even during minimal activity. Comfortable only at rest. NYHA Class IV Severe limitations. Experience symptoms even while at rest (sitting in a recliner or watching TV).
Time Frame
Baseline, 6 weeks
Title
Change in Minnesota Living with Heart Failure (MLHF) score
Description
A participant's quality of life assessed by Minnesota Living with Heart Failure (MLHF) questionnaire score.
Time Frame
Baseline, 6 weeks
Title
Change in KCCQ score
Description
A participant's quality of life assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) questionnaire score.
Time Frame
Baseline, 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Candidate for a Left Ventricular Assist Device (LVAD) Advanced Heart Failure as determined by New York Heart Association classification III or IV Exclusion Criteria: Unable to perform physical activities required by protocol due to anatomic or musculoskeletal comorbidities Physical activity is contraindicated
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sudhir S Kushwaha, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic-Rochester
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24864078
Citation
Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J. 2014 Jul;35(26):1726-31. doi: 10.1093/eurheartj/ehu197. Epub 2014 May 26.
Results Reference
background
PubMed Identifier
24486165
Citation
Dunlay SM, Park SJ, Joyce LD, Daly RC, Stulak JM, McNallan SM, Roger VL, Kushwaha SS. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014 Apr;33(4):359-65. doi: 10.1016/j.healun.2013.12.014. Epub 2013 Dec 27.
Results Reference
background
PubMed Identifier
25245832
Citation
Thalji NM, Suri RM, Greason KL, Schaff HV. Risk assessment methods for cardiac surgery and intervention. Nat Rev Cardiol. 2014 Dec;11(12):704-14. doi: 10.1038/nrcardio.2014.136. Epub 2014 Sep 23.
Results Reference
background
PubMed Identifier
22438521
Citation
Flint KM, Matlock DD, Lindenfeld J, Allen LA. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail. 2012 Mar 1;5(2):286-93. doi: 10.1161/CIRCHEARTFAILURE.111.963215. No abstract available.
Results Reference
background
PubMed Identifier
24569037
Citation
Chung CJ, Wu C, Jones M, Kato TS, Dam TT, Givens RC, Templeton DL, Maurer MS, Naka Y, Takayama H, Mancini DM, Schulze PC. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. J Card Fail. 2014 May;20(5):310-5. doi: 10.1016/j.cardfail.2014.02.008. Epub 2014 Feb 22.
Results Reference
background
PubMed Identifier
21744061
Citation
Molino-Lova R, Pasquini G, Vannetti F, Paperini A, Forconi T, Polcaro P, Zipoli R, Cecchi F, Macchi C. Effects of a structured physical activity intervention on measures of physical performance in frail elderly patients after cardiac rehabilitation: a pilot study with 1-year follow-up. Intern Emerg Med. 2013 Oct;8(7):581-9. doi: 10.1007/s11739-011-0654-z. Epub 2011 Jul 9.
Results Reference
background

Learn more about this trial

Cardiac Rehab for Advanced Heart Failure-LVAD Candidates

We'll reach out to this number within 24 hrs